Antiplatelet Therapy
22
3
3
7
Key Insights
Highlights
Success Rate
78% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 42/100
9.1%
2 terminated out of 22 trials
77.8%
-8.8% vs benchmark
36%
8 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (22)
STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD Pump
Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty.
Minimally Invasive Coronary Artery Bypass Supported by Cangrelor
Discontinuation of Antiplatelet Therapy After Drug-Coated Balloon Treatment
Safety and Efficacy of Very Short DAPT in Older Patients Undergoing PCI
T-TAS® wS Method Comparison
Early Antiplatelet Therapy After Hemorrhagic Infarction in Acute Ischemic Stroke Treated With Intravenous Thrombolysis (HITs)
DACAB Trial: Follow-up Extension
MCE Identifying Bleeding Lesions in Patients with Antiplatelet Drugs-Related Acute Non-Hematochezia Gastrointestinal Bleeding
Proton Pump Inhibitor Preventing Upper Gastrointestinal Injury In Patients On Dual Antiplatelet Therapy After CABG
Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy After Percutaneous Left Atrial Appendage Closure: a Multicenter, Randomized Study
The Influence of Gene Polymorphism on Clinical Outcomes in Patients Undergoing PCI
Platelet Aggregation in Patients With Coronary Artery Disease and Kidney Dysfunction Taking Clopidogrel or Ticagrelor
LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention
A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)
Demographical and Clinical Profile of Patients on Dual Antıplatelet Therapy and Mean Precise-DAPT and DAPT Scores in Turkey
Platelet Reactivity And Clinical ThrombotIC Events Study
Safety of Platelet Transfusion in Patients on Antiplatelet Therapy With Traumatic Head Injury
Timing of Optimal Platelet Inhibition After Acute Coronary Syndrome
Platelet Inhibition in the Acute Phase of STEMI